BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 15065856)

  • 1. Kinetic modeling confirms the biosynthesis of mucin core 1 (beta-Gal(1-3) alpha-GalNAc-O-Ser/Thr) O-glycan structures are modulated by neighboring glycosylation effects.
    Gerken TA
    Biochemistry; 2004 Apr; 43(14):4137-42. PubMed ID: 15065856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucin core O-glycosylation is modulated by neighboring residue glycosylation status. Kinetic modeling of the site-specific glycosylation of the apo-porcine submaxillary mucin tandem repeat by UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases T1 and T2.
    Gerken TA; Zhang J; Levine J; Elhammer A
    J Biol Chem; 2002 Dec; 277(51):49850-62. PubMed ID: 12397077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the site-specific oligosaccharide distribution of the O-glycans attached to the porcine submaxillary mucin tandem repeat. Further evidence for the modulation of O-glycans side chain structures by peptide sequence.
    Gerken TA; Gilmore M; Zhang J
    J Biol Chem; 2002 Mar; 277(10):7736-51. PubMed ID: 11777921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific core 1 O-glycosylation pattern of the porcine submaxillary gland mucin tandem repeat. Evidence for the modulation of glycan length by peptide sequence.
    Gerken TA; Owens CL; Pasumarthy M
    J Biol Chem; 1998 Oct; 273(41):26580-8. PubMed ID: 9756896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of peptide sequence and neighboring residue glycosylation on the substrate specificity of the uridine 5'-diphosphate-alpha-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyl transferases T1 and T2: kinetic modeling of the porcine and canine submaxillary gland mucin tandem repeats.
    Gerken TA; Tep C; Rarick J
    Biochemistry; 2004 Aug; 43(30):9888-900. PubMed ID: 15274643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.
    Hashimoto R; Fujitani N; Takegawa Y; Kurogochi M; Matsushita T; Naruchi K; Ohyabu N; Hinou H; Gao XD; Manri N; Satake H; Kaneko A; Sakamoto T; Nishimura S
    Chemistry; 2011 Feb; 17(8):2393-404. PubMed ID: 21264968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the site-specific O-glycosylation pattern of the porcine submaxillary mucin tandem repeat glycopeptide. Model proposed for the polypeptide:galnac transferase peptide binding site.
    Gerken TA; Owens CL; Pasumarthy M
    J Biol Chem; 1997 Apr; 272(15):9709-19. PubMed ID: 9092502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexpected tolerance of glycosylation by UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase revealed by electron capture dissociation mass spectrometry: carbohydrate as potential protective groups.
    Yoshimura Y; Matsushita T; Fujitani N; Takegawa Y; Fujihira H; Naruchi K; Gao XD; Manri N; Sakamoto T; Kato K; Hinou H; Nishimura S
    Biochemistry; 2010 Jul; 49(28):5929-41. PubMed ID: 20540529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site directed processing: role of amino acid sequences and glycosylation of acceptor glycopeptides in the assembly of extended mucin type O-glycan core 2.
    Brockhausen I; Dowler T; Paulsen H
    Biochim Biophys Acta; 2009 Oct; 1790(10):1244-57. PubMed ID: 19524017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro synthesis of mucin-type O-glycans using saccharide primers comprising GalNAc-Ser and GalNAc-Thr residues.
    Sakura R; Nagai K; Yagi Y; Takahashi Y; Ide Y; Yagi Y; Yamamoto D; Mizuno M; Sato T
    Carbohydr Res; 2022 Jan; 511():108495. PubMed ID: 35026558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ser and Thr acceptor preferences of the GalNAc-Ts vary among isoenzymes to modulate mucin-type O-glycosylation.
    Daniel EJP; Las Rivas M; Lira-Navarrete E; García-García A; Hurtado-Guerrero R; Clausen H; Gerken TA
    Glycobiology; 2020 Oct; 30(11):910-922. PubMed ID: 32304323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
    Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
    J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of O-glycan biosynthesis in human colon cancer tissues.
    Yang JM; Byrd JC; Siddiki BB; Chung YS; Okuno M; Sowa M; Kim YS; Matta KL; Brockhausen I
    Glycobiology; 1994 Dec; 4(6):873-84. PubMed ID: 7734850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of mucin synthesis: the peptide portion of synthetic O-glycopeptide substrates influences the activity of O-glycan core 1 UDPgalactose:N-acetyl-alpha-galactosaminyl-R beta 3-galactosyltransferase.
    Brockhausen I; Möller G; Merz G; Adermann K; Paulsen H
    Biochemistry; 1990 Nov; 29(44):10206-12. PubMed ID: 2125490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UDPgalactose:glycoprotein-N-acetyl-D-galactosamine 3-beta-D-galactosyltransferase activity synthesizing O-glycan core 1 is controlled by the amino acid sequence and glycosylation of glycopeptide substrates.
    Granovsky M; Bielfeldt T; Peters S; Paulsen H; Meldal M; Brockhausen J; Brockhausen I
    Eur J Biochem; 1994 May; 221(3):1039-46. PubMed ID: 8181460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and biosynthesis of human salivary mucins.
    Zalewska A; Zwierz K; Zółkowski K; Gindzieński A
    Acta Biochim Pol; 2000; 47(4):1067-79. PubMed ID: 11996097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution structure of O-glycosylated C-terminal leucine zipper domain of human salivary mucin (MUC7).
    Narasimhamurthy S; Naganagowda GA; Janagani S; Gururaja TL; Levine MJ
    J Biomol Struct Dyn; 2000 Aug; 18(1):145-54. PubMed ID: 11021659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic determination of the peptide acceptor preferences for the human UDP-Gal:glycoprotein-alpha-GalNAc beta 3 galactosyltransferase (T-synthase).
    Perrine C; Ju T; Cummings RD; Gerken TA
    Glycobiology; 2009 Mar; 19(3):321-8. PubMed ID: 19073881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucin-type O-glycosylation is controlled by short- and long-range glycopeptide substrate recognition that varies among members of the polypeptide GalNAc transferase family.
    Revoredo L; Wang S; Bennett EP; Clausen H; Moremen KW; Jarvis DL; Ten Hagen KG; Tabak LA; Gerken TA
    Glycobiology; 2016 Apr; 26(4):360-76. PubMed ID: 26610890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR analysis of human salivary mucin (MUC7) derived O-linked model glycopeptides: comparison of structural features and carbohydrate-peptide interactions.
    Naganagowda GA; Gururaja TL; Satyanarayana J; Levine MJ
    J Pept Res; 1999 Oct; 54(4):290-310. PubMed ID: 10532235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.